The Parenteral Drug Association Expands use of InfoStrength Smart Enterprise Suite

Released on: February 1, 2008, 5:49 am

Press Release Author: Richard Novacek

Industry: Pharmaceuticals

Press Release Summary: PDA uses InfoStrength Smart Enterprise Suite to increase
collaboration among its members worldwide.



Press Release Body: PDA uses InfoStrength Smart Enterprise Suite to increase
collaboration among its members worldwide.

InfoStrength Smart Enterprise Suite creates collaborative work environments for the
Parenteral Drug Association (PDA) worldwide Task Forces that support the development
of Technical Bulletins and Reports. These PDA products offer expert guidance, best
practices, and opinions on a variety of important scientific and regulatory topics
pertaining to pharmaceutical and biopharmaceutical production.

"InfoStrength enables more effective collaboration among the members of our many
Task Forces which in turn enables PDA to better serve the needs of our members and
the life science industry," said Rich Levy, Senior Vice President Scientific and
Regulatory Affairs at PDA.

About PDA

Connecting People, Science and Regulation
The Parenteral Drug Association (PDA) is a nonprofit international organization and
a leading global provider of science, technology, and regulatory information and
education for the pharmaceutical and biopharmaceutical community. PDA is committed
to developing scientifically sound, practical technical information and resources to
advance science and regulation through the expertise of its more than 10,000 members
worldwide. More information about PDA is available at www.pda.org.

About InfoStrength
InfoStrength, Inc., exclusively serving biotechnology, pharmaceutical and medical
device companies with internationally recognized regulatory expertise, developed
InfoStrength Smart Enterprise Suite (SES) with an innovative software development
methodology specifically created for FDA regulated environments. InfoStrength SES is
a configurable, modular, web-based application solution specifically designed to
address business and regulatory initiatives of life science companies. InfoStrength
SES enables sharing critical information while ensuring management control,
milestone accountability and market differentiating collaboration. The InfoStrength
solution delivers document, project and process management along with regulatory
compliance controls and a robust validation package. Additional information about
InfoStrength can be obtained from the company\'s website on the Internet at
www.infostrength.com



Web Site: http://www.infostrength.com/about/news/release.aspx?n=60

Contact Details: InfoStrength Inc.
4220 Apex Highway
Duite 200

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •